Intensifying competition in the domestic CRO market is eroding profits, BiDe Pharmaceutical claims it will strengthen its overseas market | Direct hit earnings conference
①Due to factors such as the slowdown in investment and financing for innovative drugs, increased competition among CRO companies, BeiDe Medicine's domestic revenue continues to decline, dragging down overall performance and leading to a sharp decrease in net income; ②In contrast, overseas market revenue remains growth, BeiDe Medicine's director, Dai Lan, revealed that there will be corresponding increase in overseas market BD personnel to carry out promotional work in the future.
Hunan oil pump: plans to invest in the construction of two large overseas bases, with an annual output of 3.5 million units of new energy electronic pump project in progress | Earnings conference
① Currently, Hunan Oil Pump's two major overseas production bases are preparing for construction according to plan; ② To observe the future production capacity increase, one should look at the progress of the annual production of 3.5 million new energy electronic pump intelligent manufacturing project.
Fushan Precision: Acquisition matters are currently being discussed with multiple parties | Directly targeting the earnings conference.
①Zheng Guangwen, the chairman of Fuchuang Precision, stated today that the company's current orders are quite sufficient, the operation is stable, and the existing production capacity can effectively meet customers' order delivery needs; ②Regarding the acquisition of 100% equity of Yisheng Precision, Zheng Guangwen stated that the acquisition is currently under discussion with multiple parties. Once completed, the acquisition will help enhance the company's comprehensive service capabilities.
Top oncology conference is coming! Multiple popular anti-cancer drugs will debut, involving these A-share companies.
①The annual meeting of the European Society for Medical Oncology will be held in Barcelona, Spain in 2024; ②At the meeting, Beigene, Jiangsu Hengrui Pharmaceuticals and other listed companies will release the latest data on their oncology drugs; ③In addition, the conference will also discuss cutting-edge topics such as the impact of artificial intelligence on the diagnosis and treatment of tumors.
The merger drama of Shijiazhuang Kelin Electric is over, and shareholders from all parties jointly formed the "cabinet" with many former executives retaining their positions. Grassroots employees: "We have confidence now."
The merger drama of Shijiazhuang Kelin Electric has come to an end, and the shareholders of all parties have finally reached a consensus and successfully completed the joint "cabinet formation", with key management positions being filled by the original management of the company. HaiXinWangnengfang obtained the positions of Chairman and Vice Chairman, and the nominee from Shijiazhuang Guotou obtained the positions of General Manager and Chairman of the Supervisory Board. All parties expressed their intention to jointly promote the company's development.
The longest shareholder meeting in history lasted for two days without ending. Hisense Network may take control of the majority of seats on the board of directors of Shijiazhuang Kelin Electric.
Shijiazhuang Kelin Electric's shareholder meeting continues to set a record for the longest duration of A-share listed company shareholder meetings. The majority of the seats on the board of directors of Hisense Networks may have been determined.
Hog farming industry rebounds, leshan giantstar farming&husbandry corporation turns loss into profit in Q2, but stock price plunges to near half! | Interpretations of financial reports.
hog farming is rebounding, leshan giantstar farming&husbandry corporation significantly reduced losses in H1 and achieved a turnaround in Q2; in H1, the company's hog production reached 1.0945 million heads, with commodity hogs reaching 1.0618 million heads, a year-on-year increase of 24.69%; although the performance has improved, the company's stock price has plummeted since June.
Shanghai SK Automation Technology's net profit in the first half of the year increased 21 times, with overseas business as the biggest highlight.
1. Overseas projects have a higher gross profit, with a significant year-on-year increase in overseas projects' confirmed income in the first half of the year; 2. The company will distribute mid-term dividends, planning to distribute a cash dividend of 3 yuan per 10 shares to all shareholders; 3. In the first half of the year, shanghai sk automation technology achieved an income of 0.794 billion yuan domestically, and overseas income reached 0.378 billion yuan.
Geling Shentong: Large models are the core technology development direction. When will the turnaround become a topic of concern for investors? | Direct hit shareholders meeting
Zhao Yong said that the large model technology is the foundation for the company's survival and development, and will also be the core technology development direction for the company in the next few years, in response to the importance of "multi-modal large model". Large models have been applied in finance, industry, commerce and other fields, but these models are auxiliary roles and have not reached the level of replacing people.
China's most profitable airline splurges 100 billion.
To create a world-class airline.
Changbaishan Invitation Letter: Insight into the Future, Welcome to Fu Peng & Liu Yuhui's Closed Thought Feast
From December 8 to December 11, on the snowy fields of Changbai Mountain, the Meet Club Winter Wilderness Tour invites you to light up the 2024 investment lights together!
There was still 180 million dollars in the previous round of “financial management”, and what is Minova's intention to sell another 600 million dollars in a fixed increase
The efficiency of capital use is yet to be tested
Navitas To Acquire Silicon Control IC Joint Venture From Halo Microelectronics For A Purchase Price Of $20M In Navitas Stock
Jiang Huawei: Zhenjiang subsidiary plans to introduce strategic investors by way of capital increase
Jiang Hua Wei (603078) announced that Zhenjiang Jianghua Micro, a wholly-owned subsidiary, intends to introduce strategic investors in the form of capital increase, which is the Golden Stone Manufacturing Industry Transformation and upgrading New Materials Fund (limited partnership). The amount of the capital increase is 280 million yuan, and the additional registered capital of the target company is 200 million yuan, and the excess part of the investment money is included in the capital accumulation fund. After the capital increase, the new materials fund is expected to hold 40% of the equity in the underlying company.
December 24 review: With sufficient reserve momentum this week, next week saw a substantial increase in trading volume as block orders targeted 5 stocks.
On December 24th, the three major indices opened higher and then fell back, with the Shanghai Composite Index maintaining a low consolidation, while the ChiNext Price Index led the decline in the two cities. In terms of sectors, the medical sector collectively surged, with traditional Chinese medicine stocks leading the gains, while food processing, retail, and other consumer stocks were active against the trend; new energy sectors such as lithium batteries, photovoltaics, and energy storage all fell across the board, with the heavyweight Contemporary Amperex Technology dropping over 9% intraday. The indices continued to weaken in the afternoon, with the ChiNext Price Index's decline expanding to 2.7% at one point. Stocks related to nurturing diamonds and the non-fungible token (NFT) concept surged, while sectors like autos, rare earths, fluorine chemicals, and digital currency remained sluggish. Overall, market sentiment is cooling, and individual stocks are showing a general downward trend in the two cities
Luoyang Glass to Exit Display Glass Business with $84 Million Disposal
BRIEF-JPMorgan Chase & Co's Long Position In Luoyang Glass Rises To 5.17% - HKEX Filing
Shinvest Sells More Espressif Shares for $4 Million
Shinvest Sells Additional Espressif Shares for Over $10 Million
Chinese Shares Break Two-Day Winning Streak; Three Debutants Stage Strong Gains